Minerva Neurosciences Inc — Quarterly Cash Flow (NASDAQ:NERV) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 42.81 M37.14 M32.8 M30.42 M28.09 M Total liabilities 64.48 M62.84 M61.95 M62.53 M62.67 M Total equity -21.67 M-25.69 M-29.15 M-32.11 M-34.58 M Total liabilities & shareholders' equities 42.81 M37.14 M32.8 M30.42 M28.09 M Total debt ————— Net debt —————

Haberler

Minerva Neurosciences, Inc. (NERV) Discusses Roluperidone as a Potential First Treatment for Negative Symptoms of Schizophrenia Transcript

Minerva Neurosciences şizofreni uzmanını yönetim kuruluna atadı

Minerva Neurosciences appoints schizophrenia expert to board of directors

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.47%

Minerva Stock Rises After Securing $200M for Schizophrenia Drug Trial - Minerva Neurosciences (NASDAQ:NERV)

Minerva Neurosciences hisseleri 200 milyon dolarlık finansman sonrası fırladı

Minerva Neurosciences stock soars after securing $200 million financing

US Stocks Mixed; Coca-Cola Posts Upbeat Earnings - American Rebel Holdings (NASDAQ:AREB), Beyond Meat (NASDAQ:BYND)